Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1
- PMID: 1712215
- DOI: 10.1089/aid.1991.7.279
Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1
Abstract
The occurrence of dominant linear antigenic sites in the envelope glycoproteins of human immunodeficiency virus type 2 (HIV-2) was evaluated. Twenty-five peptides representing different regions of HIV-2, strain SBL-6669, were synthesized. For comparison the corresponding peptides of HIV-1, strain BRU, were also prepared. The peptides were tested in enzyme-linked immunosorbent assay (ELISA) with human sera from individuals with proven HIV-1 or HIV-2 infection and simian sera from animals infected with HIV-2 or simian immunodeficiency virus of sooty mangabay monkey origin (SIVsm). Four major antigenic regions were identified. Peptides representing parts or the whole V3 (neutralizing loop) region and an additional stretch of amino acids located at the carboxy terminal of this region showed considerable reactivity. This reaction was predominantly type specific, but some heterotypic reactivity was also seen. Peptides representing the carboxy terminal 21 amino acids of the V3 region of the type-related viruses HIV-2 and SIVsm allowed selective identification of strain-specific antibodies. A second major antigenic region was found close to the carboxy terminal end of the large glycoproteins. This region was cross-reactive between the two types. The two additional dominating antigenic regions were located in the amino terminal region of the transmembrane glycoprotein. One region has previously been shown to be a uniquely antigenic type-specific site. The other region was also type-specific, but was identified only in HIV-2, amino acids Glu634-Lys649. Excellent facilities are available for the design of not only type-unique site-specific serological tests but potentially also type-cross-reactive and strain-specific assays.
Similar articles
-
Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.AIDS. 1989 Jan;3(1):17-20. AIDS. 1989. PMID: 2469436
-
Antigenic and immunogenic sites of HIV-2 glycoproteins.Chem Immunol. 1993;56:61-77. doi: 10.1159/000319156. Chem Immunol. 1993. PMID: 8452654 Review.
-
Identification of four antibody-binding sites in the envelope proteins of simian immunodeficiency virus, SIVsm.AIDS. 1993 Feb;7(2):159-65. doi: 10.1097/00002030-199302000-00002. AIDS. 1993. PMID: 7682082
-
Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.J Gen Virol. 1991 Jun;72 ( Pt 6):1261-7. doi: 10.1099/0022-1317-72-6-1261. J Gen Virol. 1991. PMID: 1710645
-
Progress with HIV vaccines.AIDS. 1991;5 Suppl 2:S129-33. doi: 10.1097/00002030-199101001-00018. AIDS. 1991. PMID: 1845044 Review. No abstract available.
Cited by
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.J Virol. 1993 Feb;67(2):863-75. doi: 10.1128/JVI.67.2.863-875.1993. J Virol. 1993. PMID: 7678308 Free PMC article.
-
Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein.J Virol. 1991 Aug;65(8):4543-6. doi: 10.1128/JVI.65.8.4543-4546.1991. J Virol. 1991. PMID: 2072463 Free PMC article.
-
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6082-6. doi: 10.1073/pnas.88.14.6082. Proc Natl Acad Sci U S A. 1991. PMID: 2068087 Free PMC article.
-
Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.J Virol. 1996 Jul;70(7):4598-606. doi: 10.1128/JVI.70.7.4598-4606.1996. J Virol. 1996. PMID: 8676486 Free PMC article.
-
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.J Virol. 1992 Jun;66(6):3602-8. doi: 10.1128/JVI.66.6.3602-3608.1992. J Virol. 1992. PMID: 1374810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources